Biederman, J, Spencer, TJ, Monuteaux, MC, Faraone, SV. A naturalistic 10-year prospective study of height and weight in children with attention-deficit hyperactivity disorder grown up: sex and treatment effects. J Pediatr 2010 Oct;157(4):635–40.CrossRefGoogle ScholarPubMed

Childress, AC, Braeckman, R, Guenther, S et al. Safety and tolerability of KP415 (serdexmethylphenidate and d-methylphenidate) capsules in children with ADHD: a 12-month, open-label safety study. Poster presented at the American Professional Society of ADHD and Related Disorders (APSARD) 2021; January 15–17.Google Scholar

Cohen, SC, Mulqueen, JM, Ferracioli-Oda, E et al. Meta-analysis: risk of tics associated with psychostimulant use in randomized, placebo-controlled trials. J Am Acad Child Adolesc Psychiatry 2015;54(9):728–36.CrossRefGoogle ScholarPubMed

Cortese, S, Adamo, N, Del Giovane, C et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry 2018;5(9):727–38.Google ScholarPubMed

Farhat, LC, Flores, JM, Behling, E et al. The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis. Mol Psychiatry 2022;27(3):1562–72.CrossRefGoogle ScholarPubMed

Jensen, PS, Arnold, LE, Swanson, JM et al. 3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry 2007;46(8):989–1002.CrossRefGoogle ScholarPubMed

Kollin, SH, Braeckman, R, Guenther, S et al. Efficacy and safety of KP415 (serdexmethylphenidate and d-methylphenidate) capsules in children with ADHD: a randomized, double-blind, placebo-controlled laboratory classroom study. Poster presented at the American Professional Society of ADHD and Related Disorders (APSARD) 2021; January 15–17.Google Scholar

The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56(12):1073–86.Google Scholar

Po, MD, Gomeni, R, Incledon, B. Quantitative characterization of the smoothness of extended-release methylphenidate pharmacokinetic profiles. Innov Clin Neurosci 2022;19(7–9):32–7.Google ScholarPubMed

Posner, K, Melvin, GA, Murray, DW et al. Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). J Child Adolesc Psychopharmacol 2007;17(5):547–62.CrossRefGoogle ScholarPubMed

Riddle, MA, Yershova, K, Lazzaretto, D et al. The Preschool Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS) 6-year follow-up. J Am Acad Child Adolesc Psychiatry 2013;52(3):264–78.CrossRefGoogle ScholarPubMed

Swanson, JM, Arnold, LE, Molina, BSG et al. Young adult outcomes in the follow-up of the multimodal treatment study of attention-deficit/hyperactivity disorder: symptom persistence, source discrepancy, and height suppression. J Child Psychol Psychiatry 2017;58(6):663–78.CrossRefGoogle ScholarPubMed

Zhang, L, Yao, H, Li, L, et al. Risk of cardiovascular diseases associated with medications used in attention-deficit/hyperactivity disorder: a systematic review and meta-analysis. JAMA Netw Open 2022;5(11):e2243597.CrossRefGoogle ScholarPubMed